drugset / Trial / NCT02719197
First-in-man Study of Single Ascending Dose of a New Drug for Neurological Disorders
RandomizedParallel-groupTriple-blindOther
Summary
The primary purpose of this first-in-man study is to investigate whether a new drug for neurological disorders is safe and well-tolerated when administered orally to healthy male adults
Timeline
- Start
- 2016-02-19
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AC-083 | Unknown | 1 mg | Oral |
| Subject | AC-083 | Unknown | 10 mg | Oral |
| Subject | AC-083 | Unknown | 100 mg | Oral |
Indications
No indication recorded.